Skip to main content

01.12.2012 | Study Protocol | Ausgabe 1/2012 Open Access

Addiction Science & Clinical Practice 1/2012

A randomized trial evaluating an mHealth system to monitor and enhance adherence to pharmacotherapy for alcohol use disorders

Addiction Science & Clinical Practice > Ausgabe 1/2012
Susan A Stoner, Christian S Hendershot
Wichtige Hinweise

Competing interests

SS declares that she is a full-time, salaried employee of Talaria, Inc., the company that developed the AGATE system. She holds no equity stake in the company. CH declares that he has no competing interests.

Authors’ contributions

SS and CH both contributed to writing this manuscript and reviewed and approved the final draft.



Nonadherence to prescribed medication regimens is a substantial barrier to the pharmacological management of alcohol use disorders. The availability of low-cost, sustainable interventions that maximize medication adherence would likely lead to improved treatment outcomes. Mobile health (mHealth) technologies are increasingly being adopted as a method of delivering behavioral health interventions and represent a promising tool for adherence interventions. We are evaluating a cell-phone–based intervention called AGATE that seeks to enhance adherence with regular text-messaging.


A randomized controlled effectiveness trial in the context of an eight-week open label naltrexone efficacy trial delivered in a naturalistic clinical setting. Treatment-seeking heavy drinkers (N = 105) are currently being recruited and randomly assigned to the AGATE intervention or a control condition. Daily measures of alcohol use and medication side effects are being recorded via cell phone in both conditions. Additionally, participants randomized to the AGATE condition receive medication reminders via SMS text message according to a schedule that adjusts according to their level of adherence.


Results from this trial will provide initial information about the feasibility and efficacy of mHealth interventions for improving adherence to alcohol pharmacotherapies.

Trial Registration

Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Addiction Science & Clinical Practice 1/2012 Zur Ausgabe